The pacemaker is the ancient warhorse of the cardiac rhythm management (CRM) business—45 years old and still ticking. One reason: companies keep improving and finding new uses for it. Along with treating arrhythmias, the major CRM companies have adapted pacemakers to become part of an increasingly successful approach to treating congestive heart failure (CHF). And now St. Jude Medical Inc. is the first CRM company to begin a clinical trial investigating whether pacemakers can treat sleep apnea.
The severe consequences that sleep apnea can produce have only recently begun to be understood. A widespread disorder that afflicts roughly 18 million Americans, including a third of all pacemaker...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?